ArticleCancer medicine2021

Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer.

Boyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.